Abstract
Epidermal growth factor (EGF) has an important role in the regulation of the proliferation and differentiation of epidermal keratinocytes, as well as in the survival, angiogenesis and metastasis of various cancer cells. There have been some reports of acneiform skin lesions that occurred in the cancer patients treated with ZD1839(Iressa®), an inhibitor of EGF tyrosine kinase. We report a case of acneiform eruption related to the anticancer drug, ZD1839(Iressa®).
Original language | English |
---|---|
Pages (from-to) | 478-481 |
Number of pages | 4 |
Journal | Korean Journal of Dermatology |
Volume | 42 |
Issue number | 4 |
Publication status | Published - 2004 Apr |
Keywords
- Acneiform eruption
- ZD1839
ASJC Scopus subject areas
- Dermatology